Stocks With The Highest
Upside Forecast

Based on 25,000+ 1-year price targets provided by 5,000+ Wall Street analysts over the past 3-months

#	Name	Upside %	Analysts bullish %
26	26 Structure Therapeutics GPCR $1.09B	280% upside 4 price targets	0
27	27 Lucid Diagnostics LUCD $123M	273% upside 3 price targets	0
28	TECX 28 Tectonic Therapeutic, Inc. Common Stock TECX $423M	265% upside 3 price targets	0
29	CAN 29 Canaan Creative CAN $332M	264% upside 4 price targets	0
30	30 Arcturus Therapeutics ARCT $374M	253% upside 3 price targets	0
31	31 PolyPid PYPD $34.4M	248% upside 4 price targets	0
32	32 Trevi Therapeutics TRVI $797M	247% upside 4 price targets	0
33	33 Abeona Therapeutics ABEO $294M	243% upside 3 price targets	0
34	34 Capricor Therapeutics CAPR $349M	242% upside 6 price targets	0
35	35 Cullinan Oncology CGEM $454M	242% upside 3 price targets	0
36	36 Lexeo Therapeutics LXEO $241M	236% upside 3 price targets	0
37	37 Cardiff Oncology CRDF $271M	232% upside 3 price targets	0
38	38 ProQR Therapeutics PRQR $244M	223% upside 4 price targets	0
39	39 Edgewise Therapeutics EWTX $1.46B	220% upside 3 price targets	0
40	40 Biohaven BHVN $1.42B	218% upside 3 price targets	0
41	41 uniQure QURE $788M	215% upside 3 price targets	0
42	42 Taysha Gene Therapies TSHA $690M	209% upside 6 price targets	0
43	43 Viking Therapeutics VKTX $3.49B	208% upside 4 price targets	0
44	44 Y-mAbs Therapeutics YMAB $197M	206% upside 3 price targets	0
45	45 Immuneering IMRX $159M	200% upside 4 price targets	0
46	46 Perspective Therapeutics CATX $295M	195% upside 4 price targets	0
47	47 Solid Biosciences SLDB $408M	195% upside 8 price targets	0
48	48 Intellia Therapeutics NTLA $1.2B	195% upside 7 price targets	0
49	49 Arrowhead Research ARWR $2.53B	186% upside 3 price targets	0
50	50 Vera Therapeutics VERA $1.52B	179% upside 4 price targets	0

12345

64